Xero share price jumps off 52-week low as ASX tech firms up ahead of holiday-shortened week
24 January 2026
2 mins read

Xero share price jumps off 52-week low as ASX tech firms up ahead of holiday-shortened week

Sydney, Jan 24, 2026, 17:01 AEDT — Market closed

  • Xero closed Friday on an uptick, bouncing back after hitting a new 52-week low just the day before.
  • Tech stocks outpaced the wider market as investors adjusted their views on rates and risk.
  • Traders are now eyeing inflation figures alongside Xero’s upcoming earnings report for guidance.

Xero Limited shares climbed 3.54% on Friday, closing at A$101.22 and reclaiming the A$100 mark after hitting a 52-week low just the day before. The stock fluctuated between A$98.40 and A$102.99 during the session. It still sits roughly 48% below its 52-week peak of A$194.21 reached in June, with a market capitalization near A$17.2 billion. 1

This shift is crucial, landing just before a long weekend and following a tough stretch for rate-sensitive growth stocks. Investors have been swift to trim and take on risk this month, with high-multiple software names bearing the brunt of the volatility.

Xero often behaves like a “long-duration” stock, a term for firms whose valuations hinge on profits expected well into the future. Rising bond yields usually push down the present value of those future earnings, sending shares lower quickly.

Australia’s benchmark index edged up Friday, with technology stocks leading the way thanks to a surge of more than 27% in Life360. The market was also buoyed by a Wall Street bounce after U.S. President Donald Trump eased off on additional tariff threats and the Greenland issue, ABC reported. 2

Some 1.53 million Xero shares traded on Friday, with turnover hitting about A$153 million, MarketIndex data shows. 3

The rebound came after Thursday’s session saw local bond yields climb, driven by an unexpected drop in unemployment. This sparked speculation about a February rate hike from the Reserve Bank of Australia, putting pressure on market segments tied to rate forecasts. 4

Dr Shane Oliver, AMP’s head of investment strategy and chief economist, said the “December quarter CPI data due Wednesday will be key” in deciding if the RBA holds rates or hikes. He noted the money market “now sees around a 57% chance of a February rate hike.” 5

Xero offers cloud-based accounting software primarily to small businesses, mostly through subscription plans. Investors tend to zero in on customer growth, pricing power, and the company’s ability to scale without ramping up spending—especially given the intense competition in accounting and payments software.

But the bounce back leaves a bigger question hanging: are investors ready to pay a premium for software stocks if rates remain stubborn? If inflation surprises on the upside or yields climb further, the sector could take another hit. Even shares that have already dropped sharply might face new selling pressure.

Australian equities will resume trading on Tuesday, following the ASX’s closure Monday for the Australia Day public holiday, according to the exchange’s trading calendar. 6

Xero’s next major event is its FY26 full-year results for the year ending March 31, set for release on May 14, per an ASX announcement. 7

Stock Market Today

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
Fortescue stock steadies after cost spike jolts FMG — what to watch after the long weekend
Previous Story

Fortescue stock steadies after cost spike jolts FMG — what to watch after the long weekend

Macquarie stock price slips into holiday week as filings flag stake shifts — here’s what matters next
Next Story

Macquarie stock price slips into holiday week as filings flag stake shifts — here’s what matters next

Go toTop